Table 2.
The sensitivity analysis from the result of the baseline and after intervention either relaxation or MBFP in period one of the cross over trial.
|
Measurement |
Group A (relaxation) |
Group B (MBFP) |
The difference of changing from baseline: Group B – Group A |
|||||
|---|---|---|---|---|---|---|---|---|
| Baseline Mean (SD) |
After Mean (SD) | Correlation R (95% CI) |
Baseline Mean (SD) |
After Mean (SD) | Correlation R (95% CI) |
Mean difference (SE) | P value | |
| Serum BDNF:ng/ml | 6.95 (3.58) | 7.59 (3.93) | 0.69 (0.38–0.86) | 6.73 (3.09) | 7.25 (2.74) | 0.60 (0.22–0.81) | 0.88 (0.77) | 0.26 |
| Cortisol: mg/dl | 12.4 (8.54) | 13.43(11.32) | 0.12 (−0.14 to0.52) | 13.12 (9.10) | 13.67 (9.45) | 0.15 (−0.23 to 0.65) | 0.07 (1.56) | 0.96 |
| Oxphos I | 1.02 (0.28) | 0.85 (0.25) | −0.69 (-0.23 to −0.89) | 1.51 (0.89) | 1.26 (0.65) | −0.39 (−0.03 to0.69) | - 0.70 (0.46) | 0.15 |
| Oxphos II | 1.93 (0.38) | 1.96 (0.41) | 0.71 0.26 to 0.90) |
2.78 (1.70) | 2.11 (2.08) | - 0.11 (-0.32 to 0.50) | −0.08 (0.24) | 0.76 |
| Oxphos III | 1.11 (0.28) | 1.08 (0.20) | 0.13 (0.43–0.62) | 1.53(0.76) | 1.33(0.46) | −0.17 (-0.26 to 0.54) | −0.17 (0.24) | 0.48 |
| Oxphos IV | 1.32(0.41) | 1.29 (0.20) | −0.68 (−0.19 to 0.88) | 1.89(1.02) | 1.54(0.77) | −0.32 (-0.12 to 0.64) | −0.26 (0.35) | 0.40 |
| Oxphos V | 1.00 (0.41) | 0.82 (0.22) | 0.68 (0.19–0.88) | 1.37(0.66) | 1.36 (0.64) | 0.39 (0.03–0.69) | 0.168 (0.22) | 0.45 |
| Clinical outcomes | ||||||||
| VAS-A 0–100 | 71.5(15.6) | 56.3(12.35) | −0.13 (−0.56 to-0.01) | 64.7(13.5) | 32.5(11.45) | −0.54 (−0.75 to 0.12) | −13.76(4.72) | 0.01 |
| Forward digit span | 7.86 (1.17) | 12.50(1.50) | −0.37 (−0.06 to −0.67) | 8.06(2.29) | 12.72(1.74) | 0.43 (0.04–0.73) | −0.24 (0.64) | 0.87 |
| Backward digit span | 3.68 (0.89) | 7.05 (0.65) | 0.11 (−0.32 to 0.49) | 3.50(0.71) | 6.89(0.58) | 0.29 (-0.20 to 0.65) | 0.02 (0.29) | 0.93 |
| Heart rate variability | ||||||||
| LF/HF ratio | 1.51(0.51) | 1.66(0.51) | 0.51 (0.11–0.76) | 1.55(0.57) | 1.58(0.37) | 0.24 -(0.25 to 0.62) |
−0.12 (0.17) | 0.47 |
| SDNN | 50.50(16.20) | 48.41(18.79) | 0.69 (0.37–0.86) | 52.94(12.46) | 48.28(21.45) | 0.47 (0.01–0.76) | 0.86 (4.97) | 0.86 |
| RMSSD | 27.77(10.84) | 25.68(12.45) | 0.38 (−0.04 to 0.68) | 28.00(9.99) | 24.78(11.58) | 0.27 (−0.22 to 0.64) | −3.02 (3.42) | 0.38 |
*p-value ≤ 0.05: statistically significant with null hypothesis the difference of mean equal 0 ** p-value ≤ 0.05: statistically significant with null hypothesis the mean of fatigue group is more than non-fatigue mean fatigue score of total 9 ± SD = 3.83 ± 0.92 in fatigue groups, 1.21 ± 0.73 in non-fatigue groups.